Shares of Castle Biosciences (CSTL) jumped by a staggering 34.66% in 30 days from $52.65 to $70.90 at 20:39 EST on Wednesday, after four successive sessions in a row of gains. NASDAQ Composite (CSTL) is falling 0.09% to $13,911.75, following the last session’s downward trend,
Castle Biosciences’s last close was $72.80, 32.4% under its 52-week high of $107.69.
Today’s last reported volume for Castle Biosciences is 249110 which is 17.57% below its average volume of 302209.
The company’s growth estimates for the present quarter and the next is a negative 362.5% and a negative 47.8%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 31%, now sitting on 68.04M for the twelve trailing months.
Castle Biosciences’s last week, last month’s, and last quarter’s current volatility was a negative 0.32%, a negative 0.08%, and a positive 3.38%, respectively.
Castle Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.29% (last week), 2.82% (last month), and 3.38% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be oversold (<=20).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $70.90 at 20:39 EST, way below its 52-week high of $107.69 and way above its 52-week low of $34.72.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is way above its 50-day moving average of $61.44 and higher than its 200-day moving average of $67.89.
More news about Castle Biosciences (CSTL).